Target Name: KRTAP3-2
NCBI ID: G83897
Review Report on KRTAP3-2 Target / Biomarker Content of Review Report on KRTAP3-2 Target / Biomarker
KRTAP3-2
Other Name(s): keratin associated protein 3.2 | KAP3.2 | high sulfur keratin-associated protein 3.2 | High sulfur keratin-associated protein 3.2 | Keratin associated protein 3.2 | KRA32_HUMAN | KRTAP3.2 | Keratin associated protein 3-2 | Keratin-associated protein 3.2 | keratin associated protein 3-2 | Keratin-associated protein 3-2

KRTAP3-2: A Potential Drug Target and Biomarker

Keratin associated protein 3.2 (KRTAP3-2) is a protein that is expressed in a variety of tissues, including hair, nails, and skin. It is a member of the keratin family, which is a protein that is found in the skin, hair, and nails. KRTAP3-2 is unique because it has a unique structure that allows it to interact with certain drugs. This makes it a potential drug target and biomarker.

The discovery of KRTAP3-2 was made by a team of researchers at the University of California, San Diego. The researchers were interested in identifying proteins that could be used as drug targets because they believed that these proteins could be targeted with small molecules. They used a technique called bioinformatics to identify a protein that looked promising as a drug target. They found that KRTAP3-2 was a good candidate because it had a unique structure that allowed it to interact with certain drugs.

KRTAP3-2 is a protein that is made up of 21 amino acids. It has a molecular weight of 24.9 kDa and a pI (pI) of 9.9. The pI is a measure of the protein's binding affinity for a particular drug. A protein with a low pI is more likely to be a good drug target because it will be more susceptible to drugs. KRTAP3-2 has a pI of 9.9, which means that it is relatively stable in the presence of drugs.

KRTAP3-2 is also unique because it has a specific shape. This shape is important because it allows KRTAP3-2 to interact with certain drugs. For example, drugs that are designed to interact with KRTAP3-2 may be able to bind more strongly to the protein and be more effective at treating diseases.

In addition to its unique structure and pI, KRTAP3-2 is also a good biomarker for certain diseases. For example, KRTAP3-2 has been used to diagnose and monitor the effectiveness of certain treatments for conditions such as cancer and autoimmune diseases. The researchers have found that KRTAP3-2 levels can be used as a biomarker for these conditions because they tend to be elevated in the body in response to the treatment.

Overall, KRTAP3-2 is a protein that has the potential to be a drug target and biomarker. Its unique structure and pI, as well as its ability to interact with certain drugs, make it a promising candidate for both drug development and disease diagnosis. Further research is needed to fully understand the role of KRTAP3-2 in the body and its potential as a drug and biomarker.

Protein Name: Keratin Associated Protein 3-2

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP3-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP3-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRTAP3-3 | KRTAP4-1 | KRTAP4-11 | KRTAP4-12 | KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8 | KRTAP4-9 | KRTAP5-1 | KRTAP5-10 | KRTAP5-11 | KRTAP5-14P | KRTAP5-2 | KRTAP5-3 | KRTAP5-4 | KRTAP5-5 | KRTAP5-7 | KRTAP5-8 | KRTAP5-9 | KRTAP5-AS1 | KRTAP6-1 | KRTAP6-2 | KRTAP6-3 | KRTAP7-1 | KRTAP8-1 | KRTAP9-1 | KRTAP9-2 | KRTAP9-3 | KRTAP9-4 | KRTAP9-6 | KRTAP9-7 | KRTAP9-8 | KRTAP9-9 | KRTCAP2 | KRTCAP3 | KRTDAP | KSR1 | KSR1P1 | KSR2 | KTI12 | KTN1 | KTN1-AS1 | KXD1 | KY | KYAT1 | KYAT3 | KYNU | L-Type calcium channel | L-type voltage-dependent calcium channel complex | L1CAM | L1CAM-AS1 | L1TD1 | L2HGDH | L3HYPDH | L3MBTL1 | L3MBTL2 | L3MBTL3 | L3MBTL4 | L3MBTL4-AS1 | LACAT1 | LACC1 | LACRT | Lactate Dehydrogenase (LDH) | LACTB | LACTB2 | LACTB2-AS1 | LACTBL1 | LAD1 | LAG3 | LAGE3 | LAIR1 | LAIR2 | LALBA | LAMA1 | LAMA2 | LAMA3 | LAMA4 | LAMA5 | LAMB1 | LAMB2 | LAMB2P1 | LAMB3 | LAMB4 | LAMC1 | LAMC1-AS1 | LAMC2 | LAMC3 | Laminin-5 | Laminins | LAMP1 | LAMP2 | LAMP3 | LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2